Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 256

1.

Pilot study: Autologous platelet-rich plasma used in a topical cream for facial rejuvenation.

Draelos ZD, Rheins LA, Wootten S, Kellar RS, Diller RB.

J Cosmet Dermatol. 2019 Jul 26. doi: 10.1111/jocd.13088. [Epub ahead of print]

PMID:
31350798
2.

Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne.

Blume-Peytavi U, Fowler J, Kemény L, Draelos Z, Cook-Bolden F, Dirschka T, Eichenfield L, Graeber M, Ahmad F, Alió Saenz A, Rich P, Tanghetti E.

J Eur Acad Dermatol Venereol. 2019 Jul 15. doi: 10.1111/jdv.15794. [Epub ahead of print]

PMID:
31306527
3.

Validation of Botanical Treatment Efficiency for Adults and Children Suffering from Mild to Moderate Atopic Dermatitis

Draelos ZD, Traub M, Gold MH, Green LJ, Amster M, Barak-Shinar D, Kircik LH.

J Drugs Dermatol. 2019 Jun 1;18(6):557.

PMID:
31251548
4.

Polymeric Emulsion Technology Applied to Tretinoin

Kircik LH, Draelos ZD, Berson DS.

J Drugs Dermatol. 2019 Apr 1;18(4):s148-154. No abstract available.

PMID:
31017754
5.

Natural Skin Care Products as Adjunctive to Prescription Therapy in Moderate to Severe Rosacea

Draelos ZD, Gunt H, Levy SB.

J Drugs Dermatol. 2019 Feb 1;18(2):141-146.

PMID:
30794364
6.

A Novel Approach to Enhancing the Quality and Appearance of Photoaged Skin

Draelos ZD.

J Drugs Dermatol. 2019 Jan 1;18(1):28-31.

PMID:
30681790
7.

Tolerability of Topical Treatments for Atopic Dermatitis.

Draelos ZD, Feldman SR, Berman B, Olivadoti M, Sierka D, Tallman AM, Zielinski MA, Ports WC, Baldwin S.

Dermatol Ther (Heidelb). 2019 Mar;9(1):71-102. doi: 10.1007/s13555-019-0280-7. Epub 2019 Jan 24. Review.

8.

BPX-01 Minocycline Topical Gel Shows Promise for the Treatment of Moderate-to-severe Inflammatory Acne Vulgaris.

Alexis A, Del Rosso JQ, Desai SR, Downie JB, Draelos ZD, Feser C, Forconi R, Fowler JF Jr, Gold M, Kaufman-Janette J, Lain E, Lee M, Ling M, Shamban AT, Werschler WP, Daniels A.

J Clin Aesthet Dermatol. 2018 Nov;11(11):25-35. Epub 2018 Nov 1.

9.

Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials

Stein-Gold L, Kircik L, Draelos ZD, Werschler P, DuBois J, Lain E, Baumann L, Goldberg D, Kaufman J, Tanghetti E, Ahluwalia G, Alvandi N, Weng E, Berk D.

J Drugs Dermatol. 2018 Nov 1;17(11):1201-1208.

PMID:
30500142
11.

Cosmeceuticals: What's Real, What's Not.

Draelos ZD.

Dermatol Clin. 2019 Jan;37(1):107-115. doi: 10.1016/j.det.2018.07.001. Epub 2018 Nov 1. Review.

PMID:
30466682
12.
13.

A novel topical minocycline foam for the treatment of moderate-to-severe acne vulgaris: Results of 2 randomized, double-blind, phase 3 studies.

Gold LS, Dhawan S, Weiss J, Draelos ZD, Ellman H, Stuart IA.

J Am Acad Dermatol. 2019 Jan;80(1):168-177. doi: 10.1016/j.jaad.2018.08.020. Epub 2018 Aug 27.

PMID:
30165171
14.

Evaluation of the Performance of a Nature-Based Sensitive Skin Regimen in Subjects With Clinically Diagnosed Sensitive Skin.

Draelos ZD, Levy SB, Lutrario C, Gunt H.

J Drugs Dermatol. 2018 Aug 1;17(8):908-913.

PMID:
30124733
15.
16.

Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302).

Baumann LS, Blauvelt A, Draelos ZD, Kempers SE, Lupo MP, Schlessinger J, Smith SR, Wilson DC, Bradshaw M, Estes E, Shanler SD.

J Am Acad Dermatol. 2018 Nov;79(5):869-877. doi: 10.1016/j.jaad.2018.05.044. Epub 2018 Jun 1. Erratum in: J Am Acad Dermatol. 2018 Nov 12;:.

17.

The Efficacy of a Ceramide-based Cream in Mild-to-moderate Atopic Dermatitis.

Draelos ZD, Raymond I.

J Clin Aesthet Dermatol. 2018 May;11(5):30-32. Epub 2018 May 1.

18.

WITHDRAWN: Efficacy and safety of topical oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 2 phase 3, 29-day, randomized, controlled REVEAL trials.

Stein-Gold L, Kircik LH, Draelos ZD, Werschler P, DuBois J, Lain E, Baumann L, Goldberg DJ, Kaufman J, Tanghetti EA, Alvandi N, Weng E, Berk DR, Ahluwalia G.

J Am Acad Dermatol. 2018 Jan 31. pii: S0190-9622(18)30147-6. doi: 10.1016/j.jaad.2018.01.028. [Epub ahead of print] Retraction in: J Am Acad Dermatol. 2019 Feb;80(2):579.

19.

Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial.

Draelos ZD, Gold MH, Weiss RA, Baumann L, Grekin SK, Robinson DM, Kempers SE, Alvandi N, Weng E, Berk DR, Ahluwalia G.

J Am Acad Dermatol. 2018 Jun;78(6):1156-1163. doi: 10.1016/j.jaad.2018.01.027. Epub 2018 Jan 31.

20.

Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.

Kircik LH, DuBois J, Draelos ZD, Werschler P, Grande K, Cook-Bolden FE, Weng E, Berk DR, Ahluwalia G.

J Drugs Dermatol. 2018 Jan 1;17(1):97-105.

PMID:
29320594
21.

The science behind skin care: Moisturizers.

Draelos ZD.

J Cosmet Dermatol. 2018 Apr;17(2):138-144. doi: 10.1111/jocd.12490. Epub 2018 Jan 10. Review.

PMID:
29319217
22.

The science behind skin care: Cleansers.

Draelos ZD.

J Cosmet Dermatol. 2018 Feb;17(1):8-14. doi: 10.1111/jocd.12469. Epub 2017 Dec 12. Review.

PMID:
29231284
23.

Cosmeceuticals for Male Skin.

Draelos ZD.

Dermatol Clin. 2018 Jan;36(1):17-20. doi: 10.1016/j.det.2017.09.003. Review.

PMID:
29108541
24.

Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled study.

Schmieder GJ, Draelos ZD, Pariser DM, Banfield C, Cox L, Hodge M, Kieras E, Parsons-Rich D, Menon S, Salganik M, Page K, Peeva E.

Br J Dermatol. 2018 Jul;179(1):54-62. doi: 10.1111/bjd.16004. Epub 2018 Mar 6.

PMID:
28949012
25.

The Role of a Natural Mollusk Egg-Derived Ingredient in Facial Appearance.

Draelos ZD.

J Drugs Dermatol. 2017 Jul 1;16(7):678-681.

PMID:
28697219
26.

A Randomized Controlled Study of a Novel Botanical Acne Spot Treatment.

Barak-Shinar D, Draelos ZD.

J Drugs Dermatol. 2017 Jun 1;16(6):599-603.

PMID:
28686778
27.

Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu.

Draelos ZD, Rodriguez DA, Kempers SE, Bruce S, Peredo MI, Downie J, Chang-Lin JE, Berk DR, Ruan S, Kaoukhov A.

J Drugs Dermatol. 2017 Jun 1;16(6):591-598.

PMID:
28686777
28.

Cosmeceuticals for rosacea.

Draelos ZD.

Clin Dermatol. 2017 Mar - Apr;35(2):213-217. doi: 10.1016/j.clindermatol.2016.10.017. Epub 2016 Oct 27.

PMID:
28274362
29.

The Anti-Aging Effects of Low Oxygen Tension Generated Multipotent Growth Factor Containing Serum.

Draelos ZD, Karnik J, Naughton G.

J Drugs Dermatol. 2017 Jan 1;16(1):30-34.

PMID:
28095530
30.

Protective effects of a novel nutritional and phytonutrient blend on ultraviolet radiation-induced skin damage and inflammatory response through aging defense mechanisms.

Wood SM, Mastaloudis AF, Hester SN, Gray R, Kern D, Namkoong J, Draelos ZD.

J Cosmet Dermatol. 2017 Dec;16(4):491-499. doi: 10.1111/jocd.12295. Epub 2016 Nov 24.

PMID:
27885783
31.

Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial.

Papp KA, Bissonnette R, Gooderham M, Feldman SR, Iversen L, Soung J, Draelos Z, Mamolo C, Purohit V, Wang C, Ports WC.

BMC Dermatol. 2016 Oct 3;16(1):15.

32.
33.

Five-day study to judge the short-term effect of a benzoyl peroxide 3% gel on acne lesions.

Draelos ZD, Ertel K, Rom D.

J Cosmet Dermatol. 2016 Dec;15(4):350-357. doi: 10.1111/jocd.12251. Epub 2016 Aug 3.

PMID:
27489202
34.

Differences in Cutaneous Irritation of Five Commonly Used Topical Products.

Draelos ZD.

J Drugs Dermatol. 2016 Jul 1;15(7):870-3.

PMID:
27391638
36.

Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open-Label, Maximal-Use Systemic Exposure Study.

Zane LT, Kircik L, Call R, Tschen E, Draelos ZD, Chanda S, Van Syoc M, Hebert AA.

Pediatr Dermatol. 2016 Jul;33(4):380-7. doi: 10.1111/pde.12872. Epub 2016 May 18.

37.

Human Stem Cell-Derived Skin Progenitors Produce Alpha 2-HS Glycoprotein (Fetuin): A Revolutionary Cosmetic Ingredient.

Nistor G, Poole AJ, Draelos Z, Lupo M, Tzikas T, Liu JH, Keirstead HS.

J Drugs Dermatol. 2016 May 1;15(5):583-98.

PMID:
27168267
38.

Bimatoprost 0.03% for the Treatment of Eyebrow Hypotrichosis.

Carruthers J, Beer K, Carruthers A, Coleman WP 3rd, Draelos ZD, Jones D, Goldman MP, Pucci ML, VanDenburgh A, Weng E, Whitcup SM.

Dermatol Surg. 2016 May;42(5):608-17. doi: 10.1097/DSS.0000000000000755.

39.

Combination Superficial Peels With Salicylic Acid and Post-Peel Retinoids.

Kligman DE, Draelos ZD.

J Drugs Dermatol. 2016 Apr;15(4):442-50.

PMID:
27050699
40.

Post Hoc Analyses of the Effect of Crisaborole Topical Ointment, 2% on Atopic Dermatitis: Associated Pruritus from Phase 1 and 2 Clinical Studies.

Draelos ZD, Stein Gold LF, Murrell DF, Hughes MH, Zane LT.

J Drugs Dermatol. 2016 Feb;15(2):172-6.

PMID:
26885784
41.

Cosmetic Drugs of Antiquity.

Draelos ZD.

J Cosmet Dermatol. 2015 Dec;14(4):267. doi: 10.1111/jocd.12189. No abstract available.

PMID:
26769135
42.

Tolerance of fragranced and fragrance-free facial cleansers in adults with clinically sensitive skin.

Draelos ZD, Fowler J, Larsen WG, Hornby S, Walters RM, Appa Y.

Cutis. 2015 Oct;96(4):269-74.

PMID:
26682289
43.
44.

A pilot study investigating the efficacy of botanical anti-inflammatory agents in an OTC eczema therapy.

Draelos ZD.

J Cosmet Dermatol. 2016 Jun;15(2):117-9. doi: 10.1111/jocd.12199. Epub 2015 Nov 24.

PMID:
26596512
45.

Novel retinoid ester in combination with salicylic acid for the treatment of acne.

Draelos Z, Lewis J, McHugh L, Pellegrino A, Popescu L.

J Cosmet Dermatol. 2016 Mar;15(1):36-42. doi: 10.1111/jocd.12190. Epub 2015 Oct 30.

PMID:
26516077
46.

New and Emerging Treatments for Rosacea.

Gold LM, Draelos ZD.

Am J Clin Dermatol. 2015 Dec;16(6):457-61. doi: 10.1007/s40257-015-0156-2. Review.

PMID:
26396117
47.

Hair care and dyeing.

Draelos ZD.

Curr Probl Dermatol. 2015;47:121-7. doi: 10.1159/000369412. Epub 2015 Feb 20. Review.

PMID:
26370650
48.
49.

Dermatological Adverse Events Associated with Topical Brimonidine Gel 0.33% in Subjects with Erythema of Rosacea: A Retrospective Review of Clinical Studies.

Holmes AD, Waite KA, Chen MC, Palaniswamy K, Wiser TH, Draelos ZD, Rafal ES, Werschler WP, Harvey AE.

J Clin Aesthet Dermatol. 2015 Aug;8(8):29-35. Review.

50.

Cosmetic Dermatology and the Distortion of Beauty.

Draelos ZD.

J Cosmet Dermatol. 2015 Sep;14(3):173. doi: 10.1111/jocd.12187. No abstract available.

PMID:
26331884

Supplemental Content

Loading ...
Support Center